These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 25972378)

  • 1. Mutations in the PP2A regulatory subunit B family genes PPP2R5B, PPP2R5C and PPP2R5D cause human overgrowth.
    Loveday C; Tatton-Brown K; Clarke M; Westwood I; Renwick A; Ramsay E; Nemeth A; Campbell J; Joss S; Gardner M; Zachariou A; Elliott A; Ruark E; van Montfort R; ; Rahman N
    Hum Mol Genet; 2015 Sep; 24(17):4775-9. PubMed ID: 25972378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPP2R5D-Related Intellectual Disability and Neurodevelopmental Delay: A Review of the Current Understanding of the Genetics and Biochemical Basis of the Disorder.
    Biswas D; Cary W; Nolta JA
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32074998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo missense variants in PPP2R5D are associated with intellectual disability, macrocephaly, hypotonia, and autism.
    Shang L; Henderson LB; Cho MT; Petrey DS; Fong CT; Haude KM; Shur N; Lundberg J; Hauser N; Carmichael J; Innis J; Schuette J; Wu YW; Asaikar S; Pearson M; Folk L; Retterer K; Monaghan KG; Chung WK
    Neurogenetics; 2016 Jan; 17(1):43-9. PubMed ID: 26576547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De Novo Mutations Affecting the Catalytic Cα Subunit of PP2A, PPP2CA, Cause Syndromic Intellectual Disability Resembling Other PP2A-Related Neurodevelopmental Disorders.
    Reynhout S; Jansen S; Haesen D; van Belle S; de Munnik SA; Bongers EMHF; Schieving JH; Marcelis C; Amiel J; Rio M; Mclaughlin H; Ladda R; Sell S; Kriek M; Peeters-Scholte CMPCD; Terhal PA; van Gassen KL; Verbeek N; Henry S; Scott Schwoerer J; Malik S; Revencu N; Ferreira CR; Macnamara E; Braakman HMH; Brimble E; Ruzhnikov MRZ; Wagner M; Harrer P; Wieczorek D; Kuechler A; Tziperman B; Barel O; de Vries BBA; Gordon CT; Janssens V; Vissers LELM
    Am J Hum Genet; 2019 Jan; 104(1):139-156. PubMed ID: 30595372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A disorder-related variant (E420K) of a PP2A-regulatory subunit (PPP2R5D) causes constitutively active AKT-mTOR signaling and uncoordinated cell growth.
    Papke CM; Smolen KA; Swingle MR; Cressey L; Heng RA; Toporsian M; Deng L; Hagen J; Shen Y; Chung WK; Kettenbach AN; Honkanen RE
    J Biol Chem; 2021; 296():100313. PubMed ID: 33482199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum: Mutations in the PP2A regulatory subunit B family genes PPP2R5B, PPP2R5C and PPP2R5D cause human overgrowth.
    Loveday C; Tatton-Brown K; Clarke M; Westwood I; Renwick A; Ramsay E; Nemeth A; Campbell J; Joss S; Gardner M; Zachariou A; Elliott A; Ruark E; Montfort RV; ; Rahman N
    Hum Mol Genet; 2019 May; 28(9):1578. PubMed ID: 30615140
    [No Abstract]   [Full Text] [Related]  

  • 7. Non-requirement of a regulatory subunit of Protein Phosphatase 2A, PP2A-B', for activation of Sex comb reduced activity in Drosophila melanogaster.
    Moazzen H; Rosenfeld R; Percival-Smith A
    Mech Dev; 2009; 126(8-9):605-10. PubMed ID: 19563886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular determinants for PP2A substrate specificity: charged residues mediate dephosphorylation of tyrosine hydroxylase by the PP2A/B' regulatory subunit.
    Saraf A; Oberg EA; Strack S
    Biochemistry; 2010 Feb; 49(5):986-95. PubMed ID: 20017541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein phosphatase 2A - structure, function and role in neurodevelopmental disorders.
    Sandal P; Jong CJ; Merrill RA; Song J; Strack S
    J Cell Sci; 2021 Jul; 134(13):. PubMed ID: 34228795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation on the PPP2R5D B regulatory subunit modulates the biochemical properties of protein phosphatase 2A.
    Yu UY; Ahn JH
    BMB Rep; 2010 Apr; 43(4):263-7. PubMed ID: 20423611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recessive syndrome of intellectual disability, moderate overgrowth, and renal dysplasia predisposing to Wilms tumor is caused by a mutation in FIBP gene.
    Akawi N; Ben-Salem S; Lahti L; Partanen J; Ali BR; Al-Gazali L
    Am J Med Genet A; 2016 Aug; 170(8):2111-8. PubMed ID: 27183861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein phosphatase 2a (PP2A) binds within the oligomerization domain of striatin and regulates the phosphorylation and activation of the mammalian Ste20-Like kinase Mst3.
    Gordon J; Hwang J; Carrier KJ; Jones CA; Kern QL; Moreno CS; Karas RH; Pallas DC
    BMC Biochem; 2011 Oct; 12():54. PubMed ID: 21985334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Phosphatase 2A (PP2A) mutations in brain function, development, and neurologic disease.
    Verbinnen I; Vaneynde P; Reynhout S; Lenaerts L; Derua R; Houge G; Janssens V
    Biochem Soc Trans; 2021 Aug; 49(4):1567-1588. PubMed ID: 34241636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability.
    Tatton-Brown K; Seal S; Ruark E; Harmer J; Ramsay E; Del Vecchio Duarte S; Zachariou A; Hanks S; O'Brien E; Aksglaede L; Baralle D; Dabir T; Gener B; Goudie D; Homfray T; Kumar A; Pilz DT; Selicorni A; Temple IK; Van Maldergem L; Yachelevich N; ; van Montfort R; Rahman N
    Nat Genet; 2014 Apr; 46(4):385-8. PubMed ID: 24614070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PP2A regulatory subunit PP2A-B' counteracts S6K phosphorylation.
    Hahn K; Miranda M; Francis VA; Vendrell J; Zorzano A; Teleman AA
    Cell Metab; 2010 May; 11(5):438-44. PubMed ID: 20444422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversity in genomic organisation, developmental regulation and distribution of the murine PR72/B" subunits of protein phosphatase 2A.
    Zwaenepoel K; Louis JV; Goris J; Janssens V
    BMC Genomics; 2008 Aug; 9():393. PubMed ID: 18715506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, neuroimaging and molecular characteristics of
    Oyama N; Vaneynde P; Reynhout S; Pao EM; Timms A; Fan X; Foss K; Derua R; Janssens V; Chung W; Mirzaa GM
    J Med Genet; 2023 May; 60(5):511-522. PubMed ID: 36216457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional importance of PP2A regulatory subunit loss in breast cancer.
    Watt LF; Panicker N; Mannan A; Copeland B; Kahl RGS; Dun MD; Young B; Roselli S; Verrills NM
    Breast Cancer Res Treat; 2017 Nov; 166(1):117-131. PubMed ID: 28744751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantum-based modeling implies that bidentate Arg
    Salter EA; Wierzbicki A; Honkanen RE; Swingle MR
    Front Cell Dev Biol; 2023; 11():1141804. PubMed ID: 37377738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B56δ-related protein phosphatase 2A dysfunction identified in patients with intellectual disability.
    Houge G; Haesen D; Vissers LE; Mehta S; Parker MJ; Wright M; Vogt J; McKee S; Tolmie JL; Cordeiro N; Kleefstra T; Willemsen MH; Reijnders MR; Berland S; Hayman E; Lahat E; Brilstra EH; van Gassen KL; Zonneveld-Huijssoon E; de Bie CI; Hoischen A; Eichler EE; Holdhus R; Steen VM; Døskeland SO; Hurles ME; FitzPatrick DR; Janssens V
    J Clin Invest; 2015 Aug; 125(8):3051-62. PubMed ID: 26168268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.